Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer.

One out of the three major indices are trading up today with the

Dow Jones Industrial Average

(

^DJI

) trading down 2 points (0.0%) at 17,750 as of Thursday, July 30, 2015, 1:05 PM ET. The NYSE advances/declines ratio sits at 1,461 issues advancing vs. 1,490 declining with 187 unchanged.

The Health Services industry currently sits down 0.4% versus the S&P 500, which is unchanged. A company within the industry that increased today was

Baxter International

(

BAX

), up 3.4%. On the negative front, top decliners within the industry include

Foundation Medicine

(

FMI

), down 22.9%,

Fresenius Medical Care AG & Co. KGaA

(

FMS

), down 5.1%,

Varian Medical Systems

(

VAR

), down 5.0%,

Teleflex

(

TFX

), down 3.9% and

HCA Holdings

(

HCA

), down 0.9%.

TheStreet would like to highlight 3 stocks pushing the industry higher today:

3.

DENTSPLY International

(

XRAY

) is one of the companies pushing the Health Services industry higher today. As of noon trading, DENTSPLY International is up $1.86 (3.5%) to $55.60 on heavy volume. Thus far, 928,068 shares of DENTSPLY International exchanged hands as compared to its average daily volume of 688,900 shares. The stock has ranged in price between $53.88-$56.18 after having opened the day at $53.94 as compared to the previous trading day's close of $53.74.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

DENTSPLY International Inc. designs, develops, manufactures, and markets various consumable dental products for the professional dental market in the United States and internationally. DENTSPLY International has a market cap of $7.4 billion and is part of the health care sector. Shares are up 0.9% year-to-date as of the close of trading on Wednesday. Currently there are 3 analysts who rate DENTSPLY International a buy, 1 analyst rates it a sell, and 6 rate it a hold.

TheStreet Ratings rates

DENTSPLY International

as a

buy

. The company's strengths can be seen in multiple areas, such as its reasonable valuation levels, expanding profit margins, good cash flow from operations, solid stock price performance and largely solid financial position with reasonable debt levels by most measures. We feel its strengths outweigh the fact that the company has had sub par growth in net income. Get the full

DENTSPLY International Ratings Report

now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

2. As of noon trading,

Hologic

(

HOLX

) is up $4.10 (10.8%) to $42.13 on heavy volume. Thus far, 7.9 million shares of Hologic exchanged hands as compared to its average daily volume of 2.1 million shares. The stock has ranged in price between $40.94-$42.35 after having opened the day at $41.50 as compared to the previous trading day's close of $38.03.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

Hologic, Inc. develops, manufactures, and supplies diagnostics products, medical imaging systems, and surgical products for women in the United States and internationally. The company operates in four segments: Diagnostics, Breast Health, GYN Surgical, and Skeletal Health. Hologic has a market cap of $10.5 billion and is part of the health care sector. Shares are up 42.2% year-to-date as of the close of trading on Wednesday. Currently there are 8 analysts who rate Hologic a buy, 1 analyst rates it a sell, and 7 rate it a hold.

TheStreet Ratings rates

Hologic

as a

buy

. The company's strengths can be seen in multiple areas, such as its impressive record of earnings per share growth, compelling growth in net income, revenue growth, expanding profit margins and good cash flow from operations. We feel its strengths outweigh the fact that the company has had generally high debt management risk by most measures that we evaluated. Get the full

Hologic Ratings Report

now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

1. As of noon trading,

Aetna

(

AET

) is up $1.04 (0.9%) to $113.64 on average volume. Thus far, 1.4 million shares of Aetna exchanged hands as compared to its average daily volume of 3.5 million shares. The stock has ranged in price between $112.36-$114.64 after having opened the day at $114.62 as compared to the previous trading day's close of $112.60.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

Aetna Inc. operates as a health care benefits company in the United States. It operates through three segments: Health Care, Group Insurance, and Large Case Pensions. Aetna has a market cap of $39.2 billion and is part of the health care sector. Shares are up 26.8% year-to-date as of the close of trading on Wednesday. Currently there are 10 analysts who rate Aetna a buy, no analysts rate it a sell, and 7 rate it a hold.

TheStreet Ratings rates

Aetna

as a

buy

. The company's strengths can be seen in multiple areas, such as its solid stock price performance, growth in earnings per share, increase in net income, revenue growth and attractive valuation levels. We feel its strengths outweigh the fact that the company shows low profit margins. Get the full

Aetna Ratings Report

now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

If you are interested in one of these 3 stocks, ETFs may be of interest. Investors who are bullish on the health services industry could consider

Health Care Select Sector SPDR

(

XLV

) while those bearish on the health services industry could consider

ProShares Ultra Short Health Care

(

RXD

).